EDGAR Filing Documents for 0001213900-23-025597

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001213900-23-025597

Filing Date

2023-03-31

Accepted

2023-03-31 17:01:09

Documents

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	f10k2022_actiniumph.htm iXBRL	10-K	1203424
2	CONSENT OF MARCUM LLP	f10k2022ex23-1_actinium.htm	EX-23.1	2398
3	CERTIFICATION	f10k2022ex31-1_actinium.htm	EX-31.1	8437
4	CERTIFICATION	f10k2022ex31-2_actinium.htm	EX-31.2	8408
5	CERTIFICATION	f10k2022ex32-1_actinium.htm	EX-32.1	4100
6	CERTIFICATION	f10k2022ex32-2_actinium.htm	EX-32.2	4147
7	GRAPHIC	image_001.jpg	GRAPHIC	181077
8	GRAPHIC	image_002.jpg	GRAPHIC	25487
9	GRAPHIC	image_003.jpg	GRAPHIC	104006
10	GRAPHIC	image_004.jpg	GRAPHIC	186595
11	GRAPHIC	image_005.jpg	GRAPHIC	92783
12	GRAPHIC	image_007.jpg	GRAPHIC	138628
13	GRAPHIC	image_008.jpg	GRAPHIC	92086
14	GRAPHIC	image_009.jpg	GRAPHIC	126867
15	GRAPHIC	image_010.jpg	GRAPHIC	73240
16	GRAPHIC	image_011.jpg	GRAPHIC	20754
17	GRAPHIC	image_012.jpg	GRAPHIC	27992
18	GRAPHIC	image_013.jpg	GRAPHIC	215949
19	GRAPHIC	image_014.jpg	GRAPHIC	162574
	Complete submission text file	0001213900-23-025597.txt		8475583

Data Files

Seq	Description	Document	Type	Size
20	XBRL SCHEMA FILE	atnm-20221231.xsd	EX-101.SCH	46972
21	XBRL CALCULATION FILE	atnm-20221231_cal.xml	EX-101.CAL	24295
22	XBRL DEFINITION FILE	atnm-20221231_def.xml	EX-101.DEF	199936
23	XBRL LABEL FILE	atnm-20221231_lab.xml	EX-101.LAB	443139
24	XBRL PRESENTATION FILE	atnm-20221231_pre.xml	EX-101.PRE	215635
69	EXTRACTED XBRL INSTANCE DOCUMENT	f10k2022_actiniumph_htm.xml	XML	385037

Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016

Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875

Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)